Chemical Component Summary

Name2-(4-butoxyphenyl)-N-hydroxyacetamide
Identifiers2-(4-butoxyphenyl)-N-oxidanyl-ethanamide
FormulaC12 H17 N O3
Molecular Weight223.27
TypeNON-POLYMER
Isomeric SMILESCCCCOc1ccc(cc1)CC(=O)NO
InChIInChI=1S/C12H17NO3/c1-2-3-8-16-11-6-4-10(5-7-11)9-12(14)13-15/h4-7,15H,2-3,8-9H2,1H3,(H,13,14)
InChIKeyMXJWRABVEGLYDG-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count33
Chiral Atom Count0
Bond Count33
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB13346 
NameBufexamac
Groups
  • approved
  • withdrawn
DescriptionBufexamac is a non-steroidal anti-inflammatory drug (NSAID) under the market name Droxaryl, Malipuran, Paraderm and Parfenac. It is typically administered topically for the treatment of subacute and chronic eczema of the skin, including atopic eczema and other inflammatory dermatoses, as well as sunburn and other minor burns, and itching. It has also been used in suppositories in combination with local anaesthetics indicated for haemorrhoids. The use of bufexamac has been discontinued in Canada and the United States, which may be due to undetermined clinical efficacy and a high prevalence of contact sensitization [A32822]. Bufexamac was also withdrawn by the EMA in April 2010.
Synonyms
  • bufexamacum
  • Bufexamac
  • Acide p-butoxyphenylacethydroxamique
  • bufexamaco
  • 4-Butoxyphenylacetohydroxamic acid
Brand Names
  • Norfemac Ointment - 5%
  • Norfemac Cream - 5%
IndicationIndicated for the treatment of various skin conditions, such as atopic eczema and other inflammatory dermatoses.
Categories
  • Acetamides
  • Acetates
  • Acetic Acid Derivatives and Related Substances
  • Acids, Acyclic
  • Agents causing hyperkalemia
ATC-Code
  • M01AB17
  • M02AA09
CAS number2438-72-4

Drug Targets

NameTarget SequencePharmacological ActionActions
Prostaglandin G/H synthase 1MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFG...unknowninhibitor
Prostaglandin G/H synthase 2MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFY...unknowninhibitor
Histone deacetylase 6MTSTGQDSTTTRQRRSRQNPQSPPQDSSVTSKRNIKKGAVPRSIPNLAEV...unknowninhibitor
Histone deacetylase 10MGTALVYHEDMTATRLLWDDPECEIERPERLTAALDRLRQRGLEQRCLRL...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
CCDC/CSDYOVCOD
PubChem2466
ChEBICHEBI:31317
ChEMBLCHEMBL94394